Economic evaluations of novel antipsychotic medications: a literature review

This publication has 38 references indexed in Scilit:

• Comparison of Discharge Rates and Drug Costs for Patients With Schizophrenia Treated With Risperidone or Olanzapine
  Psychiatric Services, 2001
• Variations in the Treatment Culture of Nursing Homes and Responses to Regulations to Reduce Drug Use
  Psychiatric Services, 2001
• Datapoints: Psychiatric Care Expenditures and Length of Stay: Trends in Industrialized Countries
  Psychiatric Services, 2000
• A 1-Year Cost-Effectiveness Model for the Treatment of Chronic Schizophrenia with Acute Exacerbations in Belgium
  Value in Health, 2000
• Clinical and economic impact of newer versus older antipsychotic medications in a community mental health center
  Clinical Therapeutics, 1999
• Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia
  PharmacoEconomics, 1999
• Risperidone
  PharmacoEconomics, 1998
• Cost Analysis of the Treatment of Schizophrenia in the UK
  PharmacoEconomics, 1998
• The added value of newer antipsychotics
  Clinical Therapeutics, 1997
• Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol
  The British Journal of Psychiatry, 1995